Skip to main content Accessibility help
×
Home

Antimicrobial Prescribing Practices in Response to Different Clostridium difficile Diagnostic Methodologies

  • Emily R. M. Sydnor (a1), Abigail Lenhart (a2), Brandon Trollinger (a3), Edina Avdic (a3), Lisa L. Maragakis (a1), Karen C. Carroll (a1) (a4) and Sara E. Cosgrove (a1)...

Abstract

We evaluated treatment decisions and antimicrobial use related to 2 testing algorithms for Clostridium difficile infection (CDI). findings suggest that a 2-step testing algorithm using rapid polymerase chain reaction confirmatory testing leads to decreased unnecessary anti-CDI antimicrobial use. In addition, a significant proportion of patients with confirmed CDI were not treated accordingto recommended guidelines.

Copyright

Corresponding author

Johns Hopkins Hospital, 600 North Wolfe Street, Osier 425, Baltimore, MD 21287 (esydnor1@jhmi.edu)

References

Hide All
1.Bartlett, JG. Narrative review: the new epidemic of Clostridium difficile-associated enteric disease. Ann Intern Med 2006; 145: 758764.
2.Reller, ME, Lema, CA, Perl, TM, et al. Yield of stool culture with isolate toxin testing versus a two-step algorithm including stool toxin testing for detection of toxigenic Clostridium difficile. J Clin Microbiol 2007;45:36013605.
3.Carroll, KC. Tests for the diagnosis of Clostridium difficile infection: the next generation. Anaerobe 2011;17:170174.
4.Walker, RC, Ruane, PJ, Rosenblatt, JE, et al. Comparison of culture, cytotoxicity assays, and enzyme-linked immunosorbent assay for toxin A and toxin B in the diagnosis of Clostridium difficile-related enteric disease. Diagn Microbiol Infect Dis 1986; 5:6169.
5.Merz, CS, Kramer, C, Forman, M, et al. Comparison of four commercially available rapid enzyme immunoassays with cytotoxin assay for detection of Clostridium difficile toxin(s) from stool specimens. J Clin Microbiol 1994;32:11421147.
6.Gerding, DN, Johnson, S, Peterson, LR, Mulligan, ME, Silva, J Jr. Clostridium difficile-associated diarrhea and colitis. Infect Control Hosp Epidemiol 1995;16:459477.
7.Mohan, SS, McDermott, BP, Parchuri, S, Cunha, BA. Lack of value of repeat stool testing for Clostridium difficile toxin. Am J Med 2006;119:356.e78.
8.Ticehurst, JR, Aird, DZ, Dam, LM, Borek, AP, Hargrove, JT, Carroll, KC. Effective detection of toxigenic Clostridium difficile by a two-step algorithm including tests for antigen and cytotoxin. J Clin Microbiol 2006;44:11451149.
9.Gilligan, PH. Is a two-step glutamate dehyrogenase antigen-cytotoxicity neutralization assay algorithm superior to the premier toxin A and B enzyme immunoassay for laboratory detection of Clostridium difficile. J Clin Microbiol 2008;46: 15231525.
10.Stamper, PD, Alcabasa, R, Aird, D, et al. Comparison of a commercial real-time PCR assay for tcdB detection to a cell culture cytotoxicity assay and toxigenic culture for direct detection of toxin-producing Clostridium difficile in clinical samples. J Clin Microbiol 2009;47:373378.
11.Bartlett, JG. Antimicrobial agents implicated in Clostridium difficile toxin-associated diarrhea of colitis. Johns Hopkins Med J 1981;149:69.
12.Kelly, CP, Pothoulakis, C, LaMont, JT. Clostridium difficile colitis. N Engl J Med 1994;330:257262.
13.Cohen, SH, Gerding, DN, Johnson, S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 2010;31:431455.

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed